Abstract
Strategies for prevention of venous thromboembolism in orthopaedic patients undergoing major lower limb surgery include pharmacological prophylaxis. Over the last three decades, the search for new safe and effective approaches for the prevention of venous thromboembolism in these patients has continued. Increased understanding of the haemostatic process has led to a clearer appreciation of the mechanisms of action of antithrombotic drugs already in use as well as the identification of new targets for novel drug development. As a result, the development of new anticoagulants has advanced rapidly over recent years. The molecular targets of several novel anticoagulants, and their effectiveness in early Phase II and Phase III trials are reviewed.
Keywords: Anticoagulants, venous thromboembolism, pulmonary embolism, haemostasis, thromboprophylaxis, antithrombotic drugs, prophylaxis, fibrinolytic mechanism, intravascular thrombosis, ticlopidine, vasoconstriction, Von Willebrand factor, serotonin, prostaglandins, factor X, antithrombin, auto-regulation, tissue factor pathway inhibitor (TFPI), Heparin, penta-saccharide, Thrombomodulin, tissue-type plasminogen, urokinase-type plasminogen activator (uPA), plasmin (via alpha2-antiplasmin), hemorhelogy, vascular bifurcations, atheromatous, Virchow's triad, sequelae, Varicose veins, pulmonary emboli, fatal pulmonary emboli, (hirudin), specific factor Xa inhibitors (fondaparinux), oral warfarin sodium, haematophagous organisms, Tifacogin, FVIIai, NAPc2, Fondaparinux, Idraparinux, DX9065a, LY 517717, Razaxaban, Rivaroxaban (BAY59-7939), SSR12517E, SSR123781A, Otamixaben, Apixaban, Ximelagatran, Dabigatran etexilate
Current Vascular Pharmacology
Title: The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery
Volume: 9 Issue: 1
Author(s): Elizabeth O. Johnson, Maria Konstandi, George C. Babis, Mara Piagkou and Panayotis N. Soucacos
Affiliation:
Keywords: Anticoagulants, venous thromboembolism, pulmonary embolism, haemostasis, thromboprophylaxis, antithrombotic drugs, prophylaxis, fibrinolytic mechanism, intravascular thrombosis, ticlopidine, vasoconstriction, Von Willebrand factor, serotonin, prostaglandins, factor X, antithrombin, auto-regulation, tissue factor pathway inhibitor (TFPI), Heparin, penta-saccharide, Thrombomodulin, tissue-type plasminogen, urokinase-type plasminogen activator (uPA), plasmin (via alpha2-antiplasmin), hemorhelogy, vascular bifurcations, atheromatous, Virchow's triad, sequelae, Varicose veins, pulmonary emboli, fatal pulmonary emboli, (hirudin), specific factor Xa inhibitors (fondaparinux), oral warfarin sodium, haematophagous organisms, Tifacogin, FVIIai, NAPc2, Fondaparinux, Idraparinux, DX9065a, LY 517717, Razaxaban, Rivaroxaban (BAY59-7939), SSR12517E, SSR123781A, Otamixaben, Apixaban, Ximelagatran, Dabigatran etexilate
Abstract: Strategies for prevention of venous thromboembolism in orthopaedic patients undergoing major lower limb surgery include pharmacological prophylaxis. Over the last three decades, the search for new safe and effective approaches for the prevention of venous thromboembolism in these patients has continued. Increased understanding of the haemostatic process has led to a clearer appreciation of the mechanisms of action of antithrombotic drugs already in use as well as the identification of new targets for novel drug development. As a result, the development of new anticoagulants has advanced rapidly over recent years. The molecular targets of several novel anticoagulants, and their effectiveness in early Phase II and Phase III trials are reviewed.
Export Options
About this article
Cite this article as:
O. Johnson Elizabeth, Konstandi Maria, C. Babis George, Piagkou Mara and N. Soucacos Panayotis, The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery, Current Vascular Pharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157016111793744779
DOI https://dx.doi.org/10.2174/157016111793744779 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Fluctuations of Melatonin and Copeptin Levels in Blood Serum During Surgical Stress Regarding the Pediatric Population
Current Pediatric Reviews Synthesis of Rutin Derivatives to Enhance Lipid Solubility and Development of Topical Formulation with a Validated Analytical Method
Current Drug Delivery P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease
Current Medicinal Chemistry Review of Erectile Dysfunction in Diabetic Animal Models
Current Diabetes Reviews Radiological Diagnosis of Renal Thrombosis in Children
Current Pediatric Reviews Genetic Variations of the Hemostatic System as Risk Factors for Venous and Arterial Thrombotic Disease
Current Genomics Ultrasound Diagnosis of Soft Tissue Vascular Malformations and Tumours
Current Medical Imaging A Qualitative and Quantitative Study of the Innervation of the Human Non Pregnant Uterus
Current Protein & Peptide Science Medical Treatment of Chronic Venous Insufficiency
Vascular Disease Prevention (Discontinued) Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies
Medicinal Chemistry Anatomical Approach to Clinical Problems of Popliteal Fossa
Current Rheumatology Reviews A Review of Current Treatment Strategies for Varicose Veins
Recent Patents on Cardiovascular Drug Discovery The Clinical Spectrum of Nephrogenic Systemic Fibrosis
Current Rheumatology Reviews Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Current Medicinal Chemistry - Anti-Cancer Agents Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Current Drug Targets Variations and Abnormalities of Major Thoracic Vascular Structures
Current Medical Imaging Glycosaminoglycan Sulodexide Inhibition of MMP-9 Gelatinase Secretion and Activity: Possible Pharmacological Role Against Collagen Degradation in Vascular Chronic Diseases
Current Vascular Pharmacology Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Alkannins and Shikonins: A New Class of Wound Healing Agents
Current Medicinal Chemistry New Drugs for Epidural Analgesia
Current Drug Targets